Order Article Reprints

Labrador J, Saiz-Rodríguez M, de Miguel D, de Laiglesia A, Rodríguez-Medina C, Vidriales MB, Pérez-Encinas M, Sánchez-Sánchez MJ, Cuello R, Roldán-Pérez A, et al. Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience. Cancers. 2022; 14(7):1734. https://doi.org/10.3390/cancers14071734

Labrador, Jorge, Miriam Saiz-Rodríguez, Dunia de Miguel, Almudena de Laiglesia, Carlos Rodríguez-Medina, María Belén Vidriales, Manuel Pérez-Encinas, María José Sánchez-Sánchez, Rebeca Cuello, Alicia Roldán-Pérez, and et al. 2022. "Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience" Cancers 14, no. 7: 1734. https://doi.org/10.3390/cancers14071734

Labrador, J., Saiz-Rodríguez, M., de Miguel, D., de Laiglesia, A., Rodríguez-Medina, C., Vidriales, M. B., Pérez-Encinas, M., Sánchez-Sánchez, M. J., Cuello, R., Roldán-Pérez, A., Vives, S., Benzo-Callejo, G., Colorado, M., García-Fortes, M., Sayas, M. J., Olivier, C., Recio, I., Conde-Royo, D., Bienert-García, Á., ... Montesinos, P. (2022). Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience. Cancers, 14(7), 1734. https://doi.org/10.3390/cancers14071734